LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -1.48%620.8M | -2.46%627M | -0.76%651.2M | -1.85%2.57B | 1.06%637.9M | -2.73%630.1M | -2.55%642.8M | -3.06%656.2M | 1.26%2.62B | -2.74%631.2M |
Operating revenue | -1.48%620.8M | -2.46%627M | -0.76%651.2M | -1.85%2.57B | 1.06%637.9M | -2.73%630.1M | -2.55%642.8M | -3.06%656.2M | 1.26%2.62B | -2.74%631.2M |
Cost of revenue | -3.34%168.1M | -5.66%168.2M | -4.68%177M | -2.34%718.5M | -0.17%180.6M | -4.35%173.9M | -4.19%178.3M | -0.64%185.7M | 0.92%735.7M | -1.09%180.9M |
Gross profit | -0.77%452.7M | -1.23%458.8M | 0.79%474.2M | -1.67%1.85B | 1.55%457.3M | -2.10%456.2M | -1.90%464.5M | -3.98%470.5M | 1.39%1.88B | -3.39%450.3M |
Operating expense | 0.40%325.9M | 0.79%318.1M | 16.03%369.1M | -8.01%1.3B | 4.75%337.3M | -2.99%324.6M | -17.43%315.6M | -13.93%318.1M | 9.03%1.41B | -9.07%322M |
Selling and administrative expenses | 1.93%226.7M | 1.02%217.5M | 21.56%262.2M | -5.01%889.2M | 16.33%235.8M | 1.32%222.4M | -16.23%215.3M | -16.04%215.7M | 3.43%936.1M | -14.07%202.7M |
-Selling and marketing expense | 4.97%149.9M | 19.97%169.4M | 32.50%190.4M | -2.98%585.7M | 24.61%158M | -1.79%142.8M | -6.98%141.2M | -20.03%143.7M | 3.78%603.7M | -17.66%126.8M |
-General and administrative expense | -3.52%76.8M | -35.09%48.1M | -0.28%71.8M | -8.69%303.5M | 2.50%77.8M | 7.42%79.6M | -29.56%74.1M | -6.74%72M | 2.78%332.4M | -7.33%75.9M |
Research and development costs | -2.94%99.2M | 0.30%100.6M | 4.39%106.9M | -13.95%406.4M | -14.92%101.5M | -11.21%102.2M | -19.89%100.3M | -9.14%102.4M | 22.14%472.3M | 0.93%119.3M |
Operating profit | -3.65%126.8M | -5.51%140.7M | -31.04%105.1M | 17.29%552.9M | -6.47%120M | 0.15%131.6M | 63.09%148.9M | 26.58%152.4M | -16.15%471.4M | 14.55%128.3M |
Net non-operating interest income expense | 25.18%-20.8M | 1.18%-25.2M | 14.47%-26M | -6.95%-110.8M | 10.56%-27.1M | -8.59%-27.8M | -8.51%-25.5M | -26.67%-30.4M | 30.05%-103.6M | -25.73%-30.3M |
Non-operating interest income | 54.62%18.4M | 33.01%13.7M | 66.67%13M | 202.84%42.7M | 128.00%11.4M | 101.69%11.9M | 312.00%10.3M | 875.00%7.8M | 1,181.82%14.1M | 1,566.67%5M |
Non-operating interest expense | -1.26%39.2M | 8.66%38.9M | 2.63%39M | 30.21%153M | 4.40%38M | 26.03%39.7M | 38.22%35.8M | 60.34%38M | -21.25%117.5M | 49.18%36.4M |
Total other finance cost | ---- | ---- | ---- | 150.00%500K | ---- | ---- | ---- | -81.82%200K | --200K | ---1.1M |
Other net income (expense) | -8.46%-42.3M | 165.75%4.8M | -333.33%-4.2M | -614.29%-50M | 9.84%-5.5M | -2,700.00%-39M | -763.64%-7.3M | 151.43%1.8M | -22.81%-7M | -19.61%-6.1M |
Gain on sale of security | -600.00%-13M | 100.00%4.8M | 55.56%2.8M | 118.57%1.3M | 9.84%-5.5M | 73.33%2.6M | 118.18%2.4M | 151.43%1.8M | -22.81%-7M | -19.61%-6.1M |
Special income (charges) | 29.57%-29.3M | --0 | ---7M | ---51.3M | --0 | ---41.6M | ---9.7M | --0 | --0 | --0 |
-Less:Impairment of capital assets | ---- | --0 | --7M | --51.3M | ---- | ---- | --9.7M | --0 | --0 | --0 |
-Write off | -29.57%29.3M | ---- | ---- | ---- | ---- | --41.6M | ---- | ---- | ---- | ---- |
Income before tax | -1.70%63.7M | 3.62%120.3M | -39.50%74.9M | 8.68%392.1M | -4.90%87.4M | -39.50%64.8M | 68.51%116.1M | 33.26%123.8M | -11.66%360.8M | 10.99%91.9M |
Income tax | -9.29%24.4M | -16.58%33.7M | -44.84%21.9M | 83.74%157.1M | 1,038.64%50.1M | -30.85%26.9M | 24.31%40.4M | 309.28%39.7M | -14.41%85.5M | 122.56%4.4M |
Net income | 3.69%39.3M | 14.40%86.6M | -36.98%53M | -14.64%235M | -57.37%37.3M | -44.43%37.9M | 107.97%75.7M | 1.08%84.1M | -10.76%275.3M | -14.47%87.5M |
Net income continuous Operations | 3.69%39.3M | 14.40%86.6M | -36.98%53M | -14.64%235M | -57.37%37.3M | -44.43%37.9M | 107.97%75.7M | 1.08%84.1M | -10.76%275.3M | -14.47%87.5M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 3.69%39.3M | 14.40%86.6M | -36.98%53M | -14.64%235M | -57.37%37.3M | -44.43%37.9M | 107.97%75.7M | 1.08%84.1M | -10.76%275.3M | -14.47%87.5M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 3.69%39.3M | 14.40%86.6M | -36.98%53M | -14.64%235M | -57.37%37.3M | -44.43%37.9M | 107.97%75.7M | 1.08%84.1M | -10.76%275.3M | -14.47%87.5M |
Basic earnings per share | 10.00%0.11 | 9.52%0.23 | -39.13%0.14 | -7.25%0.64 | -58.33%0.1 | -41.18%0.1 | 133.33%0.21 | 15.00%0.23 | -8.00%0.69 | -4.00%0.24 |
Diluted earnings per share | 10.00%0.11 | 9.52%0.23 | -39.13%0.14 | -7.25%0.64 | -58.33%0.1 | -41.18%0.1 | 133.33%0.21 | 15.00%0.23 | -8.00%0.69 | -4.00%0.24 |
Dividend per share | 0.1 | 0.1 | 0.1 | |||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |